Mixed messages on systemic therapies for diabetic retinopathy

The Lancet

Volumn 376, Issue 9751, 2010, Pages 1461-

  Lim, Laurence Shen ^a   Liew, Gerald ^b   Cheung, Ning ^c   Mitchell, Paul ^b   Wong, Tien Y ^a  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FENOFIBRATE; ANTILIPEMIC AGENT;

BLOOD PRESSURE REGULATION; DIABETIC RETINOPATHY; DISEASE COURSE; GLYCEMIC CONTROL; HUMAN; LETTER; PRIORITY JOURNAL; PROPHYLAXIS; SYSTEMIC THERAPY; BLOOD; BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; NOTE; PATHOPHYSIOLOGY;

BLOOD GLUCOSE; BLOOD PRESSURE; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FENOFIBRATE; HUMANS; HYPOLIPIDEMIC AGENTS;

EID: 78049492722     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61984-8     Document Type: Letter

References (5)

1. F Ismail-Beigi, T Craven, MA Banerji Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial Lancet 376 2010 419 430
2. The ACCORD Study Group and ACCORD Eye Study Group Effects of medical therapies on retinopathy progression in type 2 diabetes N Engl J Med 363 2010 233 244
3. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 1998 703 713
4. AC Keech, P Mitchell, PA Summanen Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial Lancet 370 2007 1687 1697
5. N Cheung, P Mitchell, TY Wong Diabetic retinopathy Lancet 376 2010 124 136